Toronto-based Highland Therapeutics is a specialty pharmaceutical company that develops proprietary drugs to treat Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms. Their oral controlled-release technology allows for evening dosing of medication with delayed and extended-release characteristics, providing next-day therapeutic activity beginning in the early morning and lasting throughout the day, addressing an unmet medical need for ADHD patients and their families during the morning routine.